Search Results - M. Patnaik
- Showing 1 - 20 results of 48
- Go to Next Page
-
1
How I diagnose and treat chronic myelomonocytic leukemia by Mrinal M. Patnaik
Published in Haematologica (2022-03-01)Get full text
Article -
2
-
3
Diagnosis and management of adult telomere biology disorders by Madeline Franke, Alejandro Ferrer, Mrinal M. Patnaik
Published in Haematologica (2025-10-01)Get full text
Article -
4
-
5
-
6
Antropološki pogledi na kovid-19 by Vesna Vučinić Nešković, Tomas Rojter, Sumendra M. Patnaik
Published in Etnoantropološki Problemi (2023-04-01)Get full text
Article -
7
-
8
-
9
Anthropological Perspectives on Covid-19 by Vesna Vučinić Nešković, Thomas Reuter, Soumendra M. Patnaik
Published in Etnoantropološki Problemi (2023-04-01)Get full text
Article -
10
Anthropological Perspectives on Covid-19 by Vesna Vučinić Nešković, Thomas Reuter, Soumendra M. Patnaik
Published in Etnoantropološki Problemi (2023-04-01)Get full text
Article -
11
-
12
P1323: PREDICTION OF NON-RELAPSE MORTALITY BY EASIX AND HCT-CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT by A. Baranwal, A. Mangaonkar, M. Shah, M. Litzow, W. Hogan, M. Patnaik, H. Alkhateeb
Published in HemaSphere (2022-06-01)Get full text
Article -
13
Retreatment with PARPi following stem cell transplant in a patient with recurrent ovarian cancer and myelodysplastic syndrome by Shilpa Mokshagundam, Mrinal M. Patnaik, Luigi A. DeVitis, Simrit K. Warring, Megan E. Grudem, Matthew S. Block
Published in Gynecologic Oncology Reports (2025-08-01)Get full text
Article -
14
-
15
P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004-2017 by N. Mclaughlin, G. Ruan, K. Wudhikarn, A. Al-Kali, A. Tefferi, N. Gangat, R. Go, M. Patnaik, M. Shah
Published in HemaSphere (2022-06-01)Get full text
Article -
16
CPX-351 (Vyxeos™) treatment in blast-phase myeloproliferative neoplasm (MPN-BP): real-world experience in 12 consecutive cases by Rimal Ilyas, Kristen McCullough, Talha Badar, Mrinal M. Patnaik, Hassan Alkhateeb, Abhishek Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Published in Blood Cancer Journal (2023-02-01)Get full text
Article -
17
Erythrocytosis associated with <i>EPAS1</i>(<i>HIF2A</i>), <i>EGLN1</i>(<i>PHD2</i>), <i>VHL, EPOR</i> or <i>BPGM</i> mutations: The Mayo Clinic experience by Naseema Gangat, Jennifer L. Oliveira, Tavanna R Porter, James D. Hoyer, Aref Al-Kali, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi
Published in Haematologica (2022-02-01)Get full text
Article -
18
Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy by Yael Kusne, Osama M. Mosalem, Jaxon Quillen, Skye Buckner-Petty, Miguel Muniz, Oliver Sartor, Geoffrey B. Johnson, Daniel S. Childs, Mrinal M. Patnaik
Published in Haematologica (2025-04-01)Get full text
Article -
19
Bone marrow findings in Erdheim-Chester disease: increased prevalence of chronic myeloid neoplasms by Gaurav Goyal, Aishwarya Ravindran, Yuanhang Liu, Rong He, Mithun V. Shah, N. Nora Bennani, Mrinal M. Patnaik, Karen L. Rech, Ronald S. Go
Published in Haematologica (2020-02-01)Get full text
Article -
20
Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation by Mrinal M. Patnaik, Prateek A. Pophali, Terra L. Lasho, Christy M. Finke, Pedro Horna, Rhett P. Ketterling, Naseema Gangat, Abhishek A. Mangaonkar, Animesh Pardanani, Ayalew Tefferi
Published in Haematologica (2019-06-01)Get full text
Article
